M. Valdés

Bernhard Meier, Kevin Walsh, B. Meier, 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Comparison of estimated glomerular filtration rate equations for dosing new oral anticoagulants in patients with atrial fibrillation.

G. Lip, S. Manzano-Fernández, E. Orenes-Piñero, 2015, Revista espanola de cardiologia.

Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk

G. Lip, M. Valdés, F. Marín, 2010, Annals of medicine.

Prediction of long‐term net clinical outcomes using the TIMI‐AF score: Comparison with CHA2DS2‐VASc and HAS‐BLED

G. Lip, M. A. Esteve-Pastor, J. Rivera‐Caravaca, 2018, American heart journal.

Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding).

G. Lip, S. Manzano-Fernández, F. Marín, 2013, The American journal of cardiology.

Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting.

G. Lip, S. Manzano-Fernández, M. Valdés, 2008, Chest.

Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.

G. Lip, M. Valdés, J. Valencia, 2008, Journal of the American College of Cardiology.

Long‐Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC‐Stroke and CHA 2 DS 2‐VASc Scores

G. Lip, M. A. Esteve-Pastor, J. Rivera‐Caravaca, 2017, Journal of the American Heart Association.

New Role of Biomarkers in Atrial Fibrillation

M. A. Esteve-Pastor, F. Marín, V. Roldán, 2015 .

Impact of Variations in Kidney Function on Nonvitamin K Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Recent Acute Heart Failure.

G. Lip, A. García-Alberola, S. Manzano-Fernández, 2016, Revista espanola de cardiologia.

Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: findings from the RIETE registry

M. Monreal, M. Valdés, C. Suárez, 2006, Journal of thrombosis and haemostasis : JTH.

The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.

G. Lip, S. Manzano-Fernández, F. Marín, 2013, Journal of the American College of Cardiology.

Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?

G. Lip, J. Rivera‐Caravaca, F. Marín, 2017, Scientific Reports.

Is the ORBIT Bleeding Risk Score Superior to the HAS-BLED Score in Anticoagulated Atrial Fibrillation Patients?

L. Badimón, Á. Cequier, M. A. Esteve-Pastor, 2016, Circulation journal : official journal of the Japanese Circulation Society.

Characteristics of sudden death in inherited heart disease.

M. Valdés, A. Alberola, D. Saura, 2010, Revista espanola de cardiologia.

Penetrance and risk profile in inherited cardiac diseases studied in a dedicated screening clinic.

A. García-Alberola, J. Gimeno, G. de la Morena, 2009, American Journal of Cardiology.

Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation.

G. Lip, J. Sánchez-Payá, S. Manzano-Fernández, 2008, European heart journal.

Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation

G. Lip, M. A. Esteve-Pastor, J. Rivera‐Caravaca, 2018, European journal of clinical investigation.

Enhancing the ‘real world’ prediction of cardiovascular events and major bleeding with the CHA2DS2-VASc and HAS-BLED scores using multiple biomarkers

M. A. Esteve-Pastor, J. Rivera‐Caravaca, F. Marín, 2018, Annals of medicine.

Efficacy of non-vitamin-K antagonist oral anticoagulants for intracardiac thrombi resolution in nonvalvular atrial fibrillation.

G. Lip, M. Valdés, E. Orenes-Piñero, 2017, Drug discovery today.

Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation

G. Lip, M. A. Esteve-Pastor, J. Rivera‐Caravaca, 2017, Scientific Reports.

The HAS-BLED score predicts long-term major bleeding and death in anticoagulated non-valvular atrial fibrillation patients undergoing electrical cardioversion.

G. Lip, F. Marín, F. Sogorb, 2016, International journal of cardiology.

Do physicians correctly calculate thromboembolic risk scores? A comparison of concordance between manual and computer‐based calculation of CHADS2 and CHA2DS2‐VASc scores

L. Badimón, M. A. Esteve-Pastor, F. Marín, 2016, Internal medicine journal.

The SAMe-TT2R2 score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral anticoagulant in patients with atrial fibrillation

G. Lip, M. A. Esteve-Pastor, F. Marín, 2016, Expert review of cardiovascular therapy.

Long-Term Predictors of Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion.

G. Lip, F. Marín, V. Roldán, 2016, Circulation journal : official journal of the Japanese Circulation Society.

The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study.

G. Lip, F. Marín, V. Vicente, 2015, The American journal of medicine.

Oral anticoagulation in Japanese patients with atrial fibrillation – insight to the use of non-vitamin K antagonist oral anticoagulants.

M. Valdés, F. Marín, Miriam Gómez-Molina, 2015, Circulation journal : official journal of the Japanese Circulation Society.

SAMe-TT2R2 score, time in therapeutic range, and outcomes in anticoagulated patients with atrial fibrillation.

G. Lip, F. Marín, V. Vicente, 2014, The American journal of medicine.

Biomarkers in atrial fibrillation: an overview

F. Marín, V. Roldán, D. Hernández-Romero, 2014, International journal of clinical practice.

Usefulness of N-Terminal Pro–B-Type Natriuretic Peptide Levels for Stroke Risk Prediction in Anticoagulated Patients With Atrial Fibrillation

G. Lip, S. Manzano-Fernández, F. Marín, 2014, Stroke.

Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation

G. Lip, F. Marín, V. Vicente, 2013, Thrombosis and Haemostasis.

The prognostic role of the adiponectin levels in atrial fibrillation

S. Manzano-Fernández, F. Marín, V. Vicente, 2013, European journal of clinical investigation.

Oral Anticoagulation Therapy in Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting With a High HAS-BLED Bleeding Risk Score ?

G. Lip, S. Manzano-Fernández, J. Valencia, 2012 .

Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a 'real world' anticoagulated atrial fibrillation population.

G. Lip, S. Manzano-Fernández, M. Valdés, 2012 .

Relation of the HAS-BLED Bleeding Risk Score to Major Bleeding, Cardiovascular Events, and Mortality in Anticoagulated Patients With Atrial Fibrillation

G. Lip, F. Marín, V. Vicente, 2012, Circulation. Arrhythmia and electrophysiology.

A comprehensive insight of novel antioxidant therapies for atrial fibrillation management

G. Lip, E. Orenes-Piñero, F. Marín, 2015, Drug metabolism reviews.

Preoperative statin therapy and troponin T predict early complications of coronary artery surgery.

M. Valdés, F. Marín, D. Pascual, 2006, The Annals of thoracic surgery.

Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?

S. Manzano-Fernández, F. Marín, G. Lip, 2013, Thrombosis and Haemostasis.

Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality

G. Lip, M. Valdés, M. A. Esteve-Pastor, 2018, International journal of clinical practice.

Usefulness of the 2MACE Score to Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation.

Á. Cequier, M. A. Esteve-Pastor, J. Rivera‐Caravaca, 2017, The American journal of cardiology.

Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients

G. Lip, M. A. Esteve-Pastor, J. Rivera‐Caravaca, 2017, Thrombosis and Haemostasis.

Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting.

G. Lip, M. Valdés, F. Marín, 2006, The American journal of cardiology.

An evaluation of the CHADS₂ stroke risk score in patients with atrial fibrillation who undergo percutaneous coronary revascularization.

G. Lip, S. Manzano-Fernández, M. Valdés, 2011, Chest.

Galectin-3 as a marker of interstitial atrial remodelling involved in atrial fibrillation

A. García-Alberola, F. Marín, E. Jover, 2017, Scientific Reports.

Clinical implications of nonsarcomeric gene polymorphisms in hypertrophic cardiomyopathy

E. Orenes-Piñero, F. Marín, V. Climent, 2016, European journal of clinical investigation.

Insights into genotype–phenotype correlation in hypertrophic cardiomyopathy. Findings from 18 Spanish families with a single mutation in MYBPC3

L. Monserrat, A. Castro‐Beiras, M. Hermida-Prieto, 2010, Heart.

[The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].

L. Monserrat, X. Fernandez, A. Castro‐Beiras, 2006, Revista espanola de cardiologia.

Ankle brachial index as an independent predictor of mortality in anticoagulated atrial fibrillation

S. Manzano-Fernández, F. Marín, V. Vicente, 2012, European journal of clinical investigation.

High sensitivity cardiac troponin T and interleukin‐6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation

S. Manzano-Fernández, F. Marín, V. Vicente, 2012, Journal of thrombosis and haemostasis : JTH.

Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation.

G. Lip, F. Marín, V. Vicente, 2012, Revista espanola de cardiologia.

Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients.

F. Marín, V. Vicente, G. Lip, 2011, Journal of the American College of Cardiology.

Anabolic status and functional impairment in men with mild chronic heart failure.

S. Manzano-Fernández, D. Pascual-Figal, G. de la Morena, 2011, The American journal of cardiology.

Short-term variability of heart rate turbulence in chronic heart failure.

J. Rojo-álvarez, A. García-Alberola, S. Manzano-Fernández, 2011, Journal of cardiac failure.

High-Sensitivity Troponin T and Copeptin in Non-ST Acute Coronary Syndromes: Implications for Prognosis and Role of hsTnT and Copeptin in Non-STEACS

S. Manzano-Fernández, M. Valdés, E. Orenes-Piñero, 2012, TheScientificWorldJournal.

Comparison between type-2 and type-1 myocardial infarction: clinical features, treatment strategies and outcomes

S. Manzano-Fernández, P. Flores-Blanco, M. Valdés, 2016, Journal of geriatric cardiology : JGC.

Unusual presentation of acute coronary syndrome. Bilateral coronary dissection after car accident.

J. Gimeno, E. Pinar, B. Redondo, 2009, The American journal of emergency medicine.

Inhibition of enzymes involved in collagen cross‐linking reduces vascular smooth muscle cell calcification

M. Valdés, F. Marín, M. Orriols, 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

CALU polymorphism A29809G affects calumenin availability involving vascular calcification.

M. Valdés, F. Marín, E. Jover, 2015, Journal of molecular and cellular cardiology.

β-Trace protein and prognosis in patients with atrial fibrillation receiving anticoagulation treatment.

G. Lip, S. Manzano-Fernández, F. Marín, 2013, Chest.

β-Trace protein: from GFR marker to cardiovascular risk predictor.

S. Manzano-Fernández, E. Orenes-Piñero, F. Marín, 2013, Clinical journal of the American Society of Nephrology : CJASN.

New Approaches to the Role of Thrombin in Acute Coronary Syndromes: Quo Vadis Bivalirudin, a Direct Thrombin Inhibitor?

M. Valdés, M. A. Esteve-Pastor, F. Marín, 2016, Molecules.

Plasma levels of von Willebrand factor are increased in patients with hypertrophic cardiomyopathy.

M. Valdés, F. Marín, F. Ruíz-Espejo, 2010, Thrombosis research.

[Prognostic value of BNP and cardiopulmonary exercise testing in patients with systolic heart failure on beta-blocker therapy].

M. Valdés, D. Pascual-Figal, J. Sánchez Más, 2008, Revista espanola de cardiologia.

Hyperuricaemia and long‐term outcome after hospital discharge in acute heart failure patients

D. Pascual-Figal, J. Ruipérez, B. Redondo, 2007, European journal of heart failure.

Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers.

S. Manzano, D. Pascual-Figal, I. Garrido, 2008, The American journal of cardiology.

Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.

F. Marín, V. Vicente, F. Ruíz-Espejo, 2008, American heart journal.

β-trace protein and cystatin C as predictors of long-term outcomes in patients with acute heart failure.

S. Manzano-Fernández, J. Januzzi, Q. Truong, 2011, Journal of the American College of Cardiology.

Metformin protects against doxorubicin-induced cardiotoxicity: involvement of the adiponectin cardiac system.

D. Pascual-Figal, J. Sánchez-Más, A. Lax, 2011, Free radical biology & medicine.

[Angiographic results of thrombectomy performed with two new devices in lesions with intracoronary thrombus].

M. Valdés, R. Lopez-Palop, D. Saura, 2003, Revista espanola de cardiologia.

Conservatively managed patients with non-ST-segment elevation acute coronary syndrome are undertreated with indicated medicines

M. Valdés, E. Orenes-Piñero, M. A. Esteve-Pastor, 2018, PloS one.

[Time intervals in primary angioplasty from onset of symptoms until restoration of blood flow].

M. Valdés, R. Lopez-Palop, D. Saura, 2002, Revista espanola de cardiologia.

Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State.

G. Lip, E. Orenes-Piñero, A. Tello-Montoliu, 2015, Journal of atherosclerosis and thrombosis.

Prognostic value of the Thrombolysis in Myocardial Infarction risk score in a unselected population with chest pain. Construction of a new predictive model.

M. Rodríguez-Barranco, D. Pascual, J. Gimeno, 2008, The American journal of emergency medicine.

[Use of a coronary risk score (the TIMI Risk Score) in a non-selected patient population assessed for chest pain at an emergency department].

D. Pascual, J. Gimeno, Josefa González, 2005, Revista espanola de cardiologia.

[Short- and medium-term outcomes of percutaneous coronary intervention for unprotected left main coronary artery disease in patients who are poor candidates for surgical revascularization].

M. Valdés, R. Lopez-Palop, D. Saura, 2004, Revista espanola de cardiologia.

Utility of the fractional flow reserve in the evaluation of angiographically moderate in-stent restenosis.

D. Saura, Mariano Valdés, I. Lozano, 2004, European heart journal.

Interleukin-6 and high-sensitivity C-reactive protein for the prediction of outcomes in non-ST-segment elevation acute coronary syndromes.

G. Lip, S. Manzano-Fernández, F. Marín, 2013, Revista espanola de cardiologia.

Impact of chronic kidney disease on major bleeding complications and mortality in patients with indication for oral anticoagulation undergoing coronary stenting.

G. Lip, S. Manzano-Fernández, M. Valdés, 2009, Chest.

Accuracy of Treadmill Testing in Assessment of Direct Myocardial Revascularization

M. Valdés, J. Crockett, B. Mccallister, 1977, Circulation.

Impact of polymorphisms in the renin–angiotensin–aldosterone system on hypertrophic cardiomyopathy

G. Lip, E. Orenes-Piñero, F. Marín, 2011, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Usefulness of High Sensitivity Troponin T Assay in Detecting Acute Allograft Rejection After Heart Transplantation

A. Minguela, M. Valdés, D. Pascual-Figal, 2011 .

[Usefulness of high sensitivity troponin T assay in detecting acute allograft rejection after heart transplantation].

A. Minguela, M. Valdés, D. Pascual-Figal, 2011, Revista espanola de cardiologia.

Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.

S. Manzano-Fernández, D. Pascual-Figal, I. Garrido, 2009, The American journal of cardiology.

Clinical presentation and outcome of venous thromboembolism in COPD

L. Bertoletti, M. Monreal, M. Valdés, 2011, European Respiratory Journal.

Red blood cell distribution width predicts long‐term outcome regardless of anaemia status in acute heart failure patients

S. Manzano-Fernández, D. Pascual-Figal, I. Garrido, 2009, European journal of heart failure.

Deciphering acute coronary syndrome biomarkers: High-resolution proteomics in platelets, thrombi and microparticles

E. Orenes-Piñero, F. Marín, Diana Navas-Carrillo, 2017, Critical reviews in clinical laboratory sciences.

Biomarkers of Necrosis and Myocardial Remodeling

E. Orenes-Piñero, F. Marín, D. Hernández-Romero, 2014 .

Red blood cell distribution width predicts new-onset anemia in heart failure patients.

S. Manzano-Fernández, J. Januzzi, D. Pascual-Figal, 2012, International journal of cardiology.

Doppler peak-plateau morphology in pulmonary regurgitation flow with respiratory changes of its profile revealing hemodynamic features of restrictive cardiomyopathy.

M. Valdés, D. Saura, I. Garrido, 2012, International journal of cardiology.

A simple echo-Doppler sign to assess improved myocardial performance after transcatheter aortic valve implantation.

M. Valdés, M. J. Oliva-Sandoval, D. Saura, 2012, International journal of cardiology.

Hypertrophic cardiomyopathy or storage cardiomyopathy? Role of genetics to predict outcome.

M. Valdés, M. J. Oliva-Sandoval, J. Gimeno, 2011, International journal of cardiology.

Short QT and dilated cardiomyopathy. A phenotype with a good prognosis?

M. Valdés, M. J. Oliva-Sandoval, J. Gimeno, 2011, International journal of cardiology.

Left atrial enlargement and NT‐proBNP as predictors of sudden cardiac death in patients with heart failure

A. Bayés‐Genís, R. Vazquez, C. Macaya, 2007, European journal of heart failure.

Effects of verapamil on indexes of heart rate variability after acute myocardial infarction.

J. L. Rojo, A. García-Alberola, T. Vicente, 1998, The American journal of cardiology.

[Implementation of the new diagnostic criteria for myocardial infarction].

M. Valdés, R. Lopez-Palop, D. Saura, 2003, Revista espanola de cardiologia.

Relation of B-type natriuretic peptide levels before and after exercise and functional capacity in patients with idiopathic dilated cardiomyopathy.

M. Valdés, D. Pascual-Figal, T. Casas, 2007, The American journal of cardiology.

[Comparative prognostic value of plasma and urinary N-terminal pro-B-type natriuretic peptide in patients with acute destabilized heart failure].

S. Manzano-Fernández, J. Januzzi, D. Pascual-Figal, 2011, Revista espanola de cardiologia.

Impact of kidney dysfunction on plasma and urinary N-terminal pro-B-type natriuretic peptide in patients with acute heart failure.

A. Bayés‐Genís, S. Manzano-Fernández, J. Januzzi, 2010, Congestive heart failure.

[Intracoronary stem cell transplantation in acute myocardial infarction].

M. Valdés, P. Tejedor, J. S. San Román, 2004, Revista espanola de cardiologia.

Sex hormone-binding globulin: a new marker of disease severity and prognosis in men with chronic heart failure.

M. Valdés, D. Pascual-Figal, I. Garrido, 2009, Revista espanola de cardiologia.

[Direct stenting in saphenous vein grafts. Immediate and long-term results].

D. Saura, I. Lozano, E. Pinar, 2005, Revista espanola de cardiologia.

Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%.

W. Zareba, A. Bayés‐Genís, I. Cygankiewicz, 2009, The American journal of cardiology.

Usefulness of clinical and NT-proBNP monitoring for prognostic guidance in destabilized heart failure outpatients.

Juan Cinca, Antoni Bayes-Genis, A. Bayés‐Genís, 2008, European heart journal.

Serial NT-proBNP monitoring and outcomes in outpatients with decompensation of heart failure.

A. Bayés‐Genís, M. Valdés, J. Ordóñez‐Llanos, 2007, International journal of cardiology.

Left atrial remodelling in hypertrophic cardiomyopathy: relation with exercise capacity and biochemical markers of tissue strain and remodelling

F. Marín, D. Saura, Josefa González, 2009, International journal of clinical practice.

An atypical presentation of Tako-Tsubo cardiomyopathy.

Pablo Peñafiel, V. Moreno, C. Nolte, 2010, International journal of cardiology.

Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting.

G. Lip, S. Manzano-Fernández, J. Valencia, 2013, Age and ageing.

Exercise eco-Doppler in hypertrophic cardiomyopathy patients. Determinant factors of exercise intolerance.

F. Marín, D. Saura, J. Gimeno, 2013, Revista espanola de cardiologia.

Aortic Valve Stenosis Planimetry by Means of Three‐Dimensional Transesophageal Echocardiography in the Real Clinical Setting: Feasibility, Reliability and Systematic Deviations

P. Flores-Blanco, M. Valdés, D. Saura, 2015, Echocardiography.

Severe aortic valve stenosis with low-gradient and preserved ejection fraction: a misclassification issue?

D. Saura, G. de la Morena, L. Caballero, 2013, Revista espanola de cardiologia.

Real-time three-dimensional transoesophageal echocardiography in the assessment of aortic valve stenosis.

F. Soria, D. Saura, Mariano Valdés, 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the “Real‐World” vs Clinical Trials

G. Lip, J. Rivera‐Caravaca, F. Marín, 2018, Mayo Clinic proceedings.

Desmoplakin truncations and arrhythmogenic left ventricular cardiomyopathy: characterizing a phenotype.

L. Monserrat, M. Valdés, J. S. Sánchez Muñoz, 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel.

D. Gallo, U. Morbiducci, F. Gaita, 2019, Revista espanola de cardiologia.

Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome.

D. Gallo, U. Morbiducci, F. Gaita, 2019, Revista espanola de cardiologia.

Venous thromboembolism in women using hormonal contraceptives

M. Monreal, M. Valdés, J. Trujillo-Santos, 2009, Thrombosis and Haemostasis.

Red Blood Cell Distribution Width Adds Prognostic Value for Outpatients With Chronic Heart Failure

S. Manzano-Fernández, D. Pascual-Figal, I. Garrido, 2012 .

Red Blood Cell Distribution Width Adds Prognostic Value for Outpatients With Chronic Heart Failure

S. Manzano-Fernández, D. Pascual-Figal, I. Garrido, 2017 .

Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Final 5-Year Report From the COMPARE II Trial (Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent).

M. Togni, P. Smits, M. Valdés, 2017, JACC. Cardiovascular interventions.

Outcomes following implantation of the biolimus A9‐eluting BioMatrix coronary stent: Primary analysis of the e‐BioMatrix registry

F. Eberli, I. Menown, M. Roffi, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: three-year follow-up of the COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-elu

M. Togni, P. Smits, J. Goy, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial

M. Togni, P. Smits, S. Hofma, 2013, The Lancet.

Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy.

F. Marín, S. Montoro-García, T. Casas, 2012, European journal of internal medicine.

Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project

J. Rivera‐Caravaca, F. Marín, V. Vicente, 2018, Journal of General Internal Medicine.

[Troponin-T monitoring in outpatients with nonischemic heart failure].

S. Manzano-Fernández, M. Valdés, D. Pascual-Figal, 2008, Revista espanola de cardiologia.

Ischemic-hemorrhagic balance in diabetic and non-diabetic patients after acute coronary syndrome

D. Gallo, U. Morbiducci, F. Gaita, 2022, REC: CardioClinics.

Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMI

D. Gallo, U. Morbiducci, F. Gaita, 2018, European heart journal. Acute cardiovascular care.

Temporal Trends in the Use of Antiplatelet Therapy in Patients With Acute Coronary Syndromes

M. Valdés, E. Orenes-Piñero, M. A. Esteve-Pastor, 2018, Journal of cardiovascular pharmacology and therapeutics.

Heart rate turbulence predicts all-cause mortality and sudden death in congestive heart failure patients.

W. Zareba, P. Caminal, I. Cygankiewicz, 2008, Heart rhythm.

Value of the "Standing Test" in the Diagnosis and Evaluation of Beta-blocker Therapy Response in Long QT Syndrome.

A. García-Alberola, D. Pascual, E. Zorio, 2017, Revista espanola de cardiologia.

Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction.

Juan Cinca, Antoni Bayes-Genis, A. Bayés‐Genís, 2009, Journal of the American College of Cardiology.

[Clinical and Preclinical Heart Failure Research Network (REDINSCOR). Instituto de Salud Carlos III Cooperative Special Topic Research Networks].

J. Brugada, M. Valdés, J. Cinca, 2008, Revista espanola de cardiologia.

Highly sensitive troponin T for risk stratification of acutely destabilized heart failure.

S. Manzano-Fernández, J. Januzzi, J. Ordóñez‐Llanos, 2012, American heart journal.

Comparison of risk prediction with the CKD-EPI and MDRD equations in acute decompensated heart failure.

S. Manzano-Fernández, P. Flores-Blanco, J. Januzzi, 2013, Journal of cardiac failure.

Effects of atorvastatin 80 mg daily on indices of matrix remodelling in 'high-risk' patients with ischemic heart disease.

G. Lip, F. Marín, V. Roldán, 2010, International journal of cardiology.

Prediction of long-term net clinical outcomes using the TIMI-AF score : Comparison with CHA 2 DS 2-VASc and HAS-BLED Cover title : Prediction of net clinical outcomes by the TIMI-AF

G. Lip, J. Rivera‐Caravaca, V. Vicente, 2017 .

Incidence, prognosis and predictors of heart failure after acute myocardial infarction

E. Abu-Assi, Maria Melendo-Viu, S. Manzano-Fernández, 2020 .

Intra-ventricular thrombus resolution after anticoagulation therapy with rivaroxaban in patient with poor anticoagulation quality.

M. Valdés, E. Orenes-Piñero, M. A. Esteve-Pastor, 2018, Cardiology journal.

Temperature affects the kinetic properties of sodium channel: fever itself unmasks the typical electrocardiographic pattern of the Brugada syndrome.

A. García-Alberola, D. Saura, Pablo Peñafiel, 2010, International journal of cardiology.

Usefulness of the 2 MACE score to predicts adverse cardiovascular events in patients with atrial fibrillation

Á. Cequier, J. Rivera‐Caravaca, F. Marín, 2017 .

[Direct Stenting without Predilation: a Single-Center Experience with 1,000 Lesions].

D. Saura, P. Carrillo, E. Pinar, 2002, Revista espanola de cardiologia.

[Direct stenting without predilatation: influence of stent diameter on the immediate results].

M. Valdés, R. Lopez-Palop, D. Saura, 2004, Revista espanola de cardiologia.

Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real-world" population with atrial fibrillation receiving anticoagulant therapy.

G. Lip, S. Manzano-Fernández, F. Marín, 2013, Chest.

Anaemia as predictor of gastrointestinal bleeding in atrial fibrillation patients undergoing percutaneous coronary artery stenting.

G. Lip, S. Manzano-Fernández, M. Valdés, 2008, QJM : monthly journal of the Association of Physicians.

S. Manzano-Fernández, P. Flores-Blanco, M. Valdés, 2015, International journal of cardiology.

[The frequency of systolic aortic regurgitation and its relationship to heart failure in a consecutive series of patients].

A. García-Alberola, F. Soria, D. Saura, 2008, Revista espanola de cardiologia.

Incidence, predictors and prognosis of new-onset cancer after hospital discharge for acute coronary syndrome

E. Abu-Assi, S. Manzano-Fernández, P. Flores-Blanco, 2019, REC: CardioClinics.

Disparities in the Estimation of Glomerular Filtration Rate According to Cockcroft‐Gault, Modification of Diet in Renal Disease‐4, and Chronic Kidney Disease Epidemiology Collaboration Equations and Relation With Outcomes in Patients With Acute Coronary Syndrome

E. Orenes-Piñero, J. Ruiz-Nodar, A. Véliz-Martínez, 2018, Journal of the American Heart Association.

Ferritin heavy chain as main mediator of preventive effect of metformin against mitochondrial damage induced by doxorubicin in cardiomyocytes.

D. Pascual-Figal, J. Sánchez-Más, A. Lax, 2014, Free radical biology & medicine.

Involvement of ferritin heavy chain in the preventive effect of metformin against doxorubicin-induced cardiotoxicity.

D. Pascual-Figal, J. Sánchez-Más, A. Lax, 2013, Free radical biology & medicine.

New perspectives in antiplatelet therapy.

D. Angiolillo, A. Tello-Montoliu, F. Marín, 2012, Current medicinal chemistry.

Hypertrophic cardiomyopathy. A study of the troponin-T gene in 127 Spanish families.

L. Monserrat, F. Marín, M. Hermida-Prieto, 2009, Revista espanola de cardiologia.

Identification and confirmation of haptoglobin as a potential serum biomarker in hypertrophic cardiomyopathy using proteomic approaches

M. Valdés, E. Orenes-Piñero, F. Marín, 2013, Annals of medicine.

Article in press-uncorrected proof Letter to the Editor Collagen peptides , interstitial remodelling and sudden cardiac death in hypertrophic cardiomyopathy

M. Valdés, F. Marín, F. Ruíz-Espejo, 2011 .

Usefulness of transoesophageal echocardiography in showing the route of anomalous coronary arteries.

M. Valdés, T. Vicente, J. López, 1996, Heart.

Incidence, clinical outcomes, and therapeutic approaches of capsule endoscopy-related adverse events in a large study population.

M. Muñoz-Navas, C. Carretero, E. Redondo-Cerezo, 2015, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[Usefulness of transesophageal echocardiography in the diagnosis of coronary anomalies].

T. Vicente, E. Pinar, F. Picó, 1996, Revista espanola de cardiologia.

Small‐size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P‐selectin

G. Lip, M. Valdés, F. Marín, 2014, British journal of haematology.

High sensitive cardiac troponin T in the management of uncertain chest pain.

M. Valdés, D. Pascual-Figal, J. Sánchez-Más, 2013, International journal of cardiology.

Three‐Dimensional Morphology of the Left Ventricular Outflow Tract: Impact on Grading Aortic Stenosis Severity

P. Lancellotti, M. J. Oliva-Sandoval, D. Saura, 2017, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Synergism between factor XII –4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction

G. Lip, F. Marín, J. Corral, 2010, Thrombosis and Haemostasis.

Von Willebrand factor is associated with atrial fibrillation development in ischaemic patients after cardiac surgery.

A. García-Alberola, F. Marín, S. Cánovas, 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

sST2 levels are associated with all‐cause mortality in anticoagulated patients with atrial fibrillation

S. Manzano-Fernández, F. Marín, V. Vicente, 2015, European journal of clinical investigation.

Serum adiponectin level as a biomarker of coronary artery calcification and severe coronary lesions.

M. Valdés, T. Casas, E. Jover, 2012, Revista espanola de cardiologia.

Temporal Changes in Platelet Response in Acute Coronary Syndrome Patients With Prasugrel and Clopidogrel After Stent Implantation.

M. Valdés, E. Orenes-Piñero, A. Tello-Montoliu, 2017, Circulation journal : official journal of the Japanese Circulation Society.

Left atrial appendage closure with amplatzer cardiac plug in atrial fibrillation: Initial European experience

Bernhard Meier, Kevin Walsh, B. Meier, 2022 .

[Comparison of drug-eluting and bare metal stents in saphenous vein grafts. Immediate and long-term results].

M. Valdés, N. Salvatella, R. Lopez-Palop, 2009, Revista espanola de cardiologia.

Comparative Determination and Monitoring of Biomarkers of Necrosis and Myocardial Remodeling between Radiofrequency Ablation and Cryoablation

A. García-Alberola, E. Orenes-Piñero, F. Marín, 2013, Pacing and clinical electrophysiology : PACE.

Brugada‐Like Electrocardiographic Pattern Induced by Fever

A. García-Alberola, D. Saura, D. Pascual, 2002, Pacing and clinical electrophysiology : PACE.

Does pacemaker implantation provide long-term benefits in severe obstructive hypertrophic cardiomyopathy?

M. Valdés, F. Marín, A. García Alberola, 2009, Revista espanola de cardiologia.

Impact of anemia as risk factor for major bleeding and mortality in patients with acute coronary syndrome.

M. Valdés, E. Orenes-Piñero, M. A. Esteve-Pastor, 2019, European journal of internal medicine.

[Effect of time elapsed from spontaneous syncope on the diagnostic performance of the head-up tilt table test].

M. Valdés, A. García Alberola, J. S. Sánchez Muñoz, 2003, Revista espanola de cardiologia.

Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry

T. Lüscher, D. Gallo, U. Morbiducci, 2020, European journal of preventive cardiology.

Prognostic value of two polymorphisms in non-sarcomeric genes for the development of atrial fibrillation in patients with hypertrophic cardiomyopathy.

E. Orenes-Piñero, F. Marín, G. Lip, 2014, QJM : monthly journal of the Association of Physicians.

Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registry.

D. Gallo, U. Morbiducci, F. Gaita, 2018, International journal of cardiology.

Soluble ST2 is a marker for acute cardiac allograft rejection.

A. Bayés‐Genís, A. Minguela, J. Ordóñez‐Llanos, 2011, The Annals of thoracic surgery.

Soluble ST 2 for Predicting Sudden Cardiac Death in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction

A. Bayés‐Genís, J. Ordóñez‐Llanos, A. Luna, 2022 .

Reproducibility of echocardiographic measurements of epicardial fat thickness.

M. Valdés, D. Saura, D. Pascual-Figal, 2010, International journal of cardiology.

Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes.

S. Manzano-Fernández, M. Valdés, E. Orenes-Piñero, 2013, Atherosclerosis.

Influence of CYP2C19 Polymorphisms in Platelet Reactivity and Prognosis in an Unselected Population of Non ST Elevation Acute Coronary Syndrome

M. Valdés, A. Tello-Montoliu, F. Marín, 2012 .

Influence of CYP 2 C 19 Polymorphisms in Platelet Reactivity and Prognosis in an Unselected Population of Non ST Elevation Acute Coronary Syndrome

M. Valdés, A. Tello-Montoliu, F. Marín, 2017 .

Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores.

G. Lip, M. Valdés, F. Marín, 2017, Thrombosis and haemostasis.

Randomized Comparison of Sirolimus-Eluting and Everolimus-Eluting Coronary Stents in the Treatment of Total Coronary Occlusions: Results From the Chronic Coronary Occlusion Treated by Everolimus-eluting Stent Randomized Trial

J. López-Sendón, M. Sabaté, Eulogio J. García, 2013, Circulation. Cardiovascular interventions.

Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary ste

P. Serruys, Chi‐Hang Lee, A. Low, 2015, JACC. Cardiovascular interventions.

A randomised trial of paclitaxel-eluting balloon after bare metal stent implantation vs. bare metal stent in ST-elevation myocardial infarction (the PEBSI study).

B. García del Blanco, S. Brugaletta, M. Sabaté, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

A randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with acute coronary syndromes: The CENTURY II high risk ACS substudy.

A. Íñiguez, S. Saito, D. Dudek, 2016, Cardiovascular revascularization medicine : including molecular interventions.

Puncture Versus Surgical Cutdown Complications of Transfemoral Aortic Valve Implantation (from the Spanish TAVI Registry).

A. Íñiguez, F. Fernández‐Avilés, B. García del Blanco, 2016, The American journal of cardiology.

Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry

D. Gallo, U. Morbiducci, C. Templin, 2019, American Journal of Cardiovascular Drugs.

Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry.

D. Gallo, U. Morbiducci, F. Gaita, 2018, Thrombosis research.

Mild kidney disease as a risk factor for major bleeding in patients with atrial fibrillation undergoing percutaneous coronary stenting

S. Manzano-Fernández, M. Valdés, E. Pinar-Bermúdez, 2011, Thrombosis and Haemostasis.

Very long-term outcome of ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study.

P. Serruys, T. Münzel, E. Schulz, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[Extrinsic compression of the left atrium as an infrequent and fatal form of type B aortic dissection: value of ECG].

T. Vicente, D. Pascual, E. Pinar, 1997, Revista espanola de cardiologia.

[Comparison between theoretical an actual intracoronary stent dimensions in non-complex lesions].

E. Pinar, F. Picó, F. Pérez-Lorente, 2006, Revista espanola de cardiologia.

Effect of Sex on Outcomes of Coronary Rotational Atherectomy Percutaneous Coronary Intervention (From the European Multicenter Euro4C Registry).

M. Valdés, E. Barbato, G. Cayla, 2020, The American journal of cardiology.

Unusual congenital coronary anomaly and myocardial ischaemia

F. Soria, D. Pascual, M. Valdés, 1999, Heart.

Pulmonary surfactant protein B in the peripheral circulation and functional impairment in patients with chronic heart failure.

M. Valdés, D. Pascual-Figal, T. Casas, 2009, Revista espanola de cardiologia.

A randomised comparison between everolimus-eluting stent and sirolimus-eluting stent in chronic coronary total occlusions. Rationale and design of the CIBELES (non-acute Coronary occlusion treated by EveroLimus-Eluting Stent) trial.

J. López-Sendón, C. Macaya, V. Martin-Yuste, 2010 .

Drug-eluting stent thrombosis in the treatment of chronic total coronary occlusions: incidence, presentation and related factors. Data from the CIBELES trial.

J. López-Sendón, M. Sabaté, M. Valdés, 2015, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

Techniques and material used in the percutaneous treatment of chronic coronary occlusions. Data from the CIBELES study.

J. López-Sendón, M. Sabaté, M. Valdés, 2013, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

Comparison of Risk Prediction With the CKD‐EPI and MDRD Equations in Non–ST‐Segment Elevation Acute Coronary Syndrome

S. Manzano-Fernández, P. Flores-Blanco, F. Marín, 2016, Clinical cardiology.

Relation of heart rate turbulence to severity of heart failure.

W. Zareba, P. Caminal, I. Cygankiewicz, 2006, The American journal of cardiology.

Major bleeding risk prediction using Chronic Kidney Disease Epidemiology Collaboration and Modification of Diet in Renal Disease equations in acute coronary syndrome

S. Manzano-Fernández, P. Flores-Blanco, F. Marín, 2015, European journal of clinical investigation.

Platelet reactivity over time in coronary artery disease patients treated with a bioabsorbable everolimus-eluting scaffold

M. Valdés, J. Ferreiro, E. Orenes-Piñero, 2016, Platelets.

Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registries.

G. Stone, D. Gallo, U. Morbiducci, 2019, American heart journal.

Influence of aortic regurgitation after TAVI on left ventricular filling pattern

D. Saura, E. Pinar, L. Caballero, 2015, European journal of clinical investigation.

Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.

F. Marín, F. Ruíz-Espejo, J. Gimeno, 2008, Journal of cardiac failure.

Therapeutic management and one-year outcomes in elderly patients with acute coronary syndrome

E. Orenes-Piñero, J. Ruiz-Nodar, V. Pernías-Escrig, 2017, Oncotarget.

Prognostic Value of QT/RR Slope in Predicting Mortality in Patients with Congestive Heart Failure

W. Zareba, A. Bayés‐Genís, I. Cygankiewicz, 2008, Journal of cardiovascular electrophysiology.

Low body weight and clinical outcomes in acute coronary syndrome patients: results of the ACHILLES Registry

M. Valdés, E. Orenes-Piñero, M. A. Esteve-Pastor, 2017, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

High-sensitivity troponin T as a biomarker for the development of atrial fibrillation after cardiac surgery.

G. Lip, A. García-Alberola, E. Orenes-Piñero, 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Heat stroke, an unusual trigger of Brugada electrocardiogram.

M. Valdés, J. Gimeno, E. García-Molina, 2009, The American journal of emergency medicine.

Association Between Ischemic and Bleeding Risk Scores and the Use of New P2Y12 Inhibitors in Patients With Acute Coronary Syndrome.

S. Raposeiras-Roubín, E. Abu-Assi, S. Manzano-Fernández, 2017, Revista espanola de cardiologia.

[Initial experience with the Impella left ventricular assist device for postcardiotomy cardiogenic shock and unprotected left coronary artery angioplasty in patients with a low left ventricular ejection fraction].

M. Valdés, J. Gimeno, E. Pinar, 2007, Revista espanola de cardiologia.

Inconclusive Exercise Stress Echocardiography in Patients With Chest Pain: Prevalence and Clinical Determinants.

S. Manzano-Fernández, P. Flores-Blanco, M. Valdés, 2017, Revista espanola de cardiologia.

Evaluation of the CRUSADE Risk Score for Predicting Major Bleeding in Patients with Concomitant Kidney Dysfunction and Acute Coronary Syndromes

S. Manzano-Fernández, P. Flores-Blanco, J. Januzzi, 2017, Cardiorenal Medicine.

VALVULAR AND STRUCTURAL HEART DISEASES Original Studies Left Atrial Appendage Closure With Amplatzer Cardiac Plug in Atrial Fibrillation: Initial European Experience

B. Meier, A. Bethencourt, H. Sievert, 2011 .

Left atrial appendage closure with amplatzer cardiac plug in atrial fibrillation: Initial European experience

B. Meier, A. Bethencourt, H. Sievert, 2022 .

[Treatment of acute myocardial infarction by primary angioplasty on-site compared with treatment following interhospital transfer: short- and long-time clinical outcomes].

M. Valdés, R. Lopez-Palop, D. Saura, 2007, Revista espanola de cardiologia.

Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation

G. Lip, J. Rivera‐Caravaca, F. Marín, 2017, Scientific Reports.

Serial Monitoring of Soluble Interleukin Family Member ST2 in Patients with Acutely Decompensated Heart Failure

S. Manzano-Fernández, D. Pascual-Figal, J. Januzzi, 2012, Cardiology.

Atrial fibrillation Von Willebrand factor is associated with atrial fibrillation development in ischaemic patients after cardiac surgery

A. García-Alberola, S. Cánovas, E. Jover, 2016 .

Novel biomarkers in cardiology: MicroRNAs in atrial fibrillation.

E. Orenes-Piñero, F. Marín, M. Valdés, 2015, Archivos de cardiologia de Mexico.

Serum levels of high-sensitivity troponin T: a novel marker for cardiac remodeling in hypertrophic cardiomyopathy.

F. Marín, T. Casas, P. Martínez, 2010, Journal of cardiac failure.

CALU A29809G polymorphism in coronary atherothrombosis: Implications for coronary calcification and prognosis

J. Ruiz-Nodar, A. Tello-Montoliu, F. Marín, 2010, Annals of medicine.

Soluble ST 2 Monitoring Provides Additional Risk Stratification for Outpatients With Decompensated Heart Failure

A. Bayés‐Genís, A. Maisel, M. Valdés, 2017 .

TWEAK and NT‐proBNP levels predict exercise capacity in hypertrophic cardiomyopathy

M. Valdés, E. Orenes-Piñero, F. Marín, 2015, European journal of clinical investigation.

Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in 'real-world' atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients.

G. Lip, M. Valdés, M. A. Esteve-Pastor, 2017, International journal of cardiology.

SAMe-TT2R2 Score Does Not Predict Time in Therapeutic Range in Atrial Fibrillation Patients After Hospitalization for Acute Decompensated Heart Failure.

S. Manzano-Fernández, P. Flores-Blanco, M. Valdés, 2016, Revista espanola de cardiologia.

[Comparison of intracoronary ultrasound expansion parameters in coronary stents implanted with or without balloon predilatation. A randomized intravascular ultrasound study].

D. Saura, P. Carrillo, E. Pinar, 2004, Revista espanola de cardiologia.

[Long-term prognosis of patients with myocardial bridge and angiographic milking of the left anterior descending coronary artery].

M. Valdés, I. Lozano, E. Pinar, 2002, Revista espanola de cardiologia.

Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry

D. Gallo, U. Morbiducci, C. Templin, 2019, American Journal of Cardiovascular Drugs.

Red Blood Cell Distribution Width Adds Prognostic Value for Outpatients With Chronic Heart Failure

S. Manzano-Fernández, D. Pascual-Figal, I. Garrido, 2012 .

Short-term variability of heart rate turbulence in chronic heart failure.

J. Rojo-álvarez, A. García-Alberola, S. Manzano-Fernández, 2011, Journal of cardiac failure.

Soluble ST2 is a marker for acute cardiac allograft rejection.

A. Bayés‐Genís, A. Minguela, J. Ordóñez‐Llanos, 2011, The Annals of thoracic surgery.

Role of microRNAs in cardiac remodelling: new insights and future perspectives.

G. Lip, E. Orenes-Piñero, F. Marín, 2013, International journal of cardiology.

Novel biomarkers in cardiology: MicroRNAs in atrial fibrillation.

E. Orenes-Piñero, F. Marín, M. Valdés, 2015, Archivos de Cardiología de México.

An insight of novel pharmacological therapies in hypertrophic cardiomyopathy.

E. Orenes-Piñero, F. Marín, G. de la Morena, 2011, Medicinal chemistry.

Pre and post-operative treatments for prevention of atrial fibrillation after cardiac surgery.

G. Lip, A. Banerjee, E. Orenes-Piñero, 2012, Mini reviews in medicinal chemistry.

Involvement of the −420C>G RETN polymorphism in myocardial fibrosis in patients with hypertrophic cardiomyopathy

E. Orenes-Piñero, F. Marín, S. Cánovas, 2015, Journal of internal medicine.

Aortic Valve Stenosis Planimetry by Means of Three‐Dimensional Transesophageal Echocardiography in the Real Clinical Setting: Feasibility, Reliability and Systematic Deviations

P. Flores-Blanco, D. Saura, L. Caballero, 2015, Echocardiography.

Prognostic Value of Mean Platelet Volume in Patients With Non-ST-Elevation Acute Coronary Syndrome

M. Valdés, A. Tello-Montoliu, F. Marín, 2012, Angiology.

Impact of Variations in Kidney Function on Nonvitamin K Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Recent Acute Heart Failure.

G. Lip, A. García-Alberola, S. Manzano-Fernández, 2016, Revista espanola de cardiologia.

Glycoprotein inhibitors in patients on chronic anticoagulation: Safe enough or too much risk?

M. Valdés, F. Marín, B. Bonacasa, 2009, Thrombosis and Haemostasis.

Long-Term Predictors of Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion.

G. Lip, F. Marín, V. Roldán, 2016, Circulation journal : official journal of the Japanese Circulation Society.

Factor VII –323 decanucleotide D/I polymorphism in atrial fibrillation: Implications for the prothrombotic state and stroke risk

G. Lip, F. Marín, J. Corral, 2008, Annals of medicine.

Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol.

G. Lip, M. Valdés, M. A. Esteve-Pastor, 2018, Clinical therapeutics.

The SAMe-TT2R2 score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral anticoagulant in patients with atrial fibrillation

G. Lip, F. Marín, V. Roldán, 2016, Expert review of cardiovascular therapy.

Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): the PLATINUM PLUS all-comers randomised trial.

S. Silber, F. Neumann, A. Zaman, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[Comparison of intracoronary ultrasound expansion parameters in coronary stents implanted with or without balloon predilatation. A randomized intravascular ultrasound study].

D. Saura, P. Carrillo, E. Pinar, 2004, Revista espanola de cardiologia.

Early results of direct coronary stenting in consecutive patients when multivessel, complex, long lesions, and small vessels are included.

M. Valdés, A. Bethencourt, J. M. Hernandez, 2005, International journal of cardiology.

Sex hormone-binding globulin: a new marker of disease severity and prognosis in men with chronic heart failure.

D. Pascual-Figal, I. Garrido, J. Sánchez-Más, 2009, Revista Española de Cardiología.

Is oral anticoagulation needed in patients with atrial fibrillation and stent implantation at low-moderate risk of stroke?

G. Lip, L. Fauchier, D. Angoulvant, 2016, European journal of internal medicine.

Prognostic value of the Thrombolysis in Myocardial Infarction risk score in a unselected population with chest pain. Construction of a new predictive model.

M. Rodríguez-Barranco, D. Pascual, J. Gimeno, 2008, The American journal of emergency medicine.

Interleukin‐6 as a predictor of cardiovascular events in troponin‐negative non‐ST elevation acute coronary syndrome patients

S. Manzano-Fernández, A. Tello-Montoliu, F. Marín, 2014, International journal of clinical practice.

[The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].

L. Monserrat, X. Fernandez, A. Castro‐Beiras, 2006, Revista espanola de cardiologia.